Save your favourite. The tentative approval by the US Food & Drug Administration (USFDA) was for Ribociclib tablets of strength 200 mg, Alembic Pharmaceuticals said in a regulatory filing.

Alembic Pharmaceuticals Limited on Friday announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Divalproex ...

The United States Food and Drug Administration (USFDA) granted final approval on Tuesday to Alembic Pharmaceuticals Ltd for Ivabradine tablets, a medication for lowering hospitalisations due to ...